En lo alto de un empinado acantilado de granito a unas dos horas en coche al oeste de Kiev, cientos de personas montaron ...

The Moderna Innovation and Technology Centre (MITC) at Harwell Science and Innovation Campus. Moderna and the University of Oxford in the UK have been cleared to start human trials of what could be ...

Add Yahoo as a preferred source to see more of our stories on Google. Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A sign marks the offices of Moderna in Cambridge, Massachusetts, U.S., July 22, 2025. REUTERS/Brian Snyder/File Photo ...

Moderna's MRNA.O mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on ...

Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European ...

The Food and Drug Administration's decision, made public on Feb. 10, to not review an application to approve Moderna's proposed mRNA-based flu vaccine set off a firestorm of criticism from public ...

European drug regulators recommended authorizing Moderna’s combined vaccine against Covid-19 and the flu, paving the way for the shot’s approval in the European Union at a time the company is facing ...

Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by Pfizer (PFE) and BioNTech (BNTX), marking the latest such case among ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...